Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ana M. Della Rocca"'
Autor:
Ana M. Della Rocca, Fernanda S. Tonin, Mariana M. Fachi, Alexandre F. Cobre, Vinicius L. Ferreira, Letícia P. Leonart, Giovanna Steffenello-Durigon, Joanita A. G. Del Moral, Luana Lenzi, Roberto Pontarolo
Publikováno v:
Diseases, Vol 9, Iss 2, p 43 (2021)
Burkitt lymphoma/leukemia (BL/L) is an aggressive oncohematological disease. This study evaluated the population-based prognosis and survival on BL/L as well as if BL/L behaved as a risk factor for the development of second primary cancers (SPCs) and
Externí odkaz:
https://doaj.org/article/49a7027c11fe435c9421c1a9cc38b403
Autor:
Fernanda S. Tonin, Roberto Pontarolo, Aline F. Bonetti, Fernando Fernandez-Llimos, Rosa Camila Lucchetta, Ana M. Della Rocca
Publikováno v:
International Journal of Clinical Pharmacy. 42:1252-1260
Background: Suboptimal meta-analyses with misleading conclusions are frequently published in the health areas, and they can compromise decision making in clinical practice. Aim of the review: This systematic review aimed to map the characteristics of
Autor:
Mariana Millan Fachi, Vinicius Lins Ferreira, Luana Lenzi, Roberto Pontarolo, Fernanda S. Tonin, Ana M. Della Rocca, Joanita Angela Gonzaga Del Moral, Giovanna Steffenello-Durigon, Alexandre de Fátima Cobre, Letícia P. Leonart
Publikováno v:
Diseases, Vol 9, Iss 43, p 43 (2021)
Diseases
Volume 9
Issue 2
Diseases
Volume 9
Issue 2
Burkitt lymphoma/leukemia (BL/L) is an aggressive oncohematological disease. This study evaluated the population-based prognosis and survival on BL/L as well as if BL/L behaved as a risk factor for the development of second primary cancers (SPCs) and
Publikováno v:
Current Drug Therapy. 14:210-219
Background:Second generation direct acting-antivirals are safe and effective treatments for chronic hepatitis C patients.Objective:We aimed to conduct a systematic review of case reports and case series to evaluate the safety of the drugs, highlighti
Autor:
Ana M. Della Rocca, Joanita Angela Gonzaga Del Moral, Vinicius Lins Ferreira, Letícia P. Leonart, Fernando Fernandez-Llimos, Fernanda S. Tonin, Roberto Pontarolo, Giovanna Steffenello-Durigon
Publikováno v:
Clinical lymphoma, myelomaleukemia. 21(8)
Background Burkitt lymphoma (BL) is an aggressive hematologic cancer. This study synthetized the evidence about the efficacy and safety of chemotherapy treatments used in patients with BL using the World Health Organization classification. Materials